University of Maryland School of Medicine logo
Emergency Medicine
All Departments
UMSOM Assistant

UMEM Educational Pearls

  • Home
  • Departments
  • Emergency Medicine
  • CME
  • UMEM Educational Pearls
  • CME
  • Courses and Conferences
  • Free Open Access Medical Education
  • UMEM Educational Pearls
Previous |  1 |  2 |  3 |  4 |  5 |  6 |  ... |  237 |  Next

Title: The Greater Occipital Nerve Block

Category: Neurology

Keywords: migraine, greater occipital nerve block, headache (PubMed Search)

Posted: 8/11/2026 by Nicholas Contillo, MD

The 2025 American Headache Society guidelines give the greater occipital nerve (GON) block a level A recommendation for ED migraine treatment, boldly calling it a “must offer” therapy for migraine patients requiring parenteral treatment.

  • Mechanism: 
    • The GON, a branch of the C2 spinal nerve, innervates the posterior scalp and converges with trigeminal afferents at the C2 dorsal horn. Blocking the GON dampens trigeminal signaling at this convergence point, reducing acute migraine pain. Since central sensitization drives migraine chronicity, benefits often outlast the local anesthetic, persisting for weeks to months.
  • Efficacy: 
    • A meta-analysis of over 400 patients showed a mean reduction of 3.6 headache days/month and lower pain severity scores versus controls, with greater benefit from scheduled, recurring blocks. For acute migraine, one large study found 82% of patients reported moderate-to-significant relief.
  • How to:
    • Positioning: 
      • Seat the patient with the head flexed slightly forward. Avoid any lateral or rotational movement, which may distort landmarks.
    • Landmark-based: 
      • Palpate the external occipital protuberance and mastoid process. The GON runs about one-third of the distance (2-4 cm) between them, just medial to the occipital artery (which is often palpable). Prep the skin, advance the needle while aspirating until you hit bone, withdraw slightly, then inject 1-3 mL of 1% lidocaine or 0.5% bupivacaine with a fanning technique.
    • Ultrasound-guided (more precise): 
      • Place a linear probe with sterile cover transversely over the occipital protuberance, then slide down to the C2 spinous process, which has a characteristic bifid appearance. Moving laterally from here, identify the GON between the semispinalis capitis and obliquus capitis inferior fascial plane, medial to the occipital artery (consider color Doppler to confirm). Inject 1-3 mL of anesthetic into this fascial plane, avoiding injection into the nerve fascicles themselves.
    • Adjuncts? 
      • Dexamethasone mixed with local anesthetic has evidence of benefit with cervicogenic headache and occipital neuralgia, but has no proven added benefit for migraine specifically.

Bottom Line: Consider adding the GON block to your toolkit for migraine treatment in the ED.

Show References

  1. Robblee, J., Minen, M. T., Friedman, B. W., Cortel-LeBlanc, M. A., Cortel-LeBlanc, A., & Orr, S. L. (2026). 2025 guideline update to acute treatment of migraine for adults in the emergency department: The American Headache Society evidence assessment of parenteral pharmacotherapies. Headache: The Journal of Head and Face Pain, 66(1), 53-76.
  2. Palamar, D., Uluduz, D., Saip, S., Erden, G., Unalan, H., & Akarirmak, U. (2015). Ultrasound-guided greater occipital nerve block: an efficient technique in chronic refractory migraine without aura?. Pain Physician, 18(2), 153.
  3. NYSORA. https://nysora.com/pain-management/ultrasound-guided-greater-occipital-nerve-block/


Title: Autonomous Oxygen Titration

Category: Critical Care

Posted: 8/11/2026 by Mark Sutherland, MD

Rarely do more than a few months go by without us posting yet another pearl about the dangers of hypoxemia or hyperoxemia.  The data in general is strong that patients with significant exposure to either very high or very low oxygen levels do worse than patients with normoxia.  But if the first step intervention is simple – if the SpO2/PaO2 is high, turn the oxygen support down, and if the SpO2/PaO2 is low, turn the oxygen support up - then in this day and age can we improve this with a closed-loop system?  Click the Additional Information to find out!

Show Additional Information

Douin et al recently published the SAVE-O2 AI trial.  It used the O2matic PRO100 (of note, it is approved in Europe and Australia/New Zealand, but NOT currently FDA approved in the US), which autotitrates the oxygen flow rate to maintain a goal SpO2 (usually of 90-96%).  This study was not powered to look at patient outcomes, but they did find statistically significant greater time in goal SpO2 range for the autonomous system vs standard care.  Their primary outcome was time under an SpO2 of 87%, but I was even more interested in time above 96%, which dropped from 29% in the standard care group to 9% in the autonomous device group, because we know often times we are not good about turning the oxygen DOWN when the saturation is high.  

Bottom Line: Autonomous closed-loop oxygen titration devices likely increase time in goal SpO2 range.  Whether they impact the outcomes of hospitalized patients remains unknown.



Title: Acetaminophen is SAFE in pregnancy...

Category: Administration

Posted: 8/10/2026 by Jennifer Wang, MD (Updated: 8/12/2026)

…Which we knew already, but in case you need help convincing your patients, this meta-analysis came out just a few months ago and looked at 43 different studies in a systematic review (17 in a meta-analysis) totaling >300000 patients evaluated and showed that there is NO association between acetaminophen/paracetamol in pregnancy and autism/ADHD/intellectual disabilities.

Show References

Prenatal paracetamol exposure and child neurodevelopment: a systematic review and meta-analysis

D'Antonio F, Flacco M, Valle L et al.

The Lancet Obstetrics, Gynaecology, & Women’s Health, 2026; 2, e190-e198



Title: Post firearm injury infections

Category: Trauma

Keywords: Gsw, infection, complication, firearm, injury (PubMed Search)

Posted: 8/9/2026 by Robert Flint, MD (Updated: 8/12/2026)

These authors used a database of 323 hospitals to find over 20,000 firearm injured patients. They looked at positive cultures to assess for post injury infection. Infection rate was 5%. Most infections were in the immediate post injury period. Those with surgical procedures on head, neck, lower abdomen, and spine were most likely to develop infection. Infection did not appear to be associated with increased mortality.  Current guidelines recommend antibiotics for the first 24 hours post injury only.

Show References

Yang J, Tung CC, Harfouche MN, Baghdadi JD. Bacterial Infections in US Adults with Firearm Injuries. JAMA Netw Open. 2026;9(8):e2627109. doi:10.1001/jamanetworkopen.2026.27109



Title: "I've got this in room 8 but I'm all alone"

Category: Orthopedics

Posted: 8/8/2026 by Brian Corwell, MD (Updated: 8/12/2026)

https://prod-images-static.radiopaedia.org/images/2208864/f4cb459274ce88e8169d3baf9334dd_big_gallery.jpeg

Show Additional Information

Elbow dislocations

The 2nd most common large joint dislocation

Over 90% are posterior or posterolateral

Most commonly caused by a fall on an outstretched hand

Single provider reduction technique:

Leverage technique

The leverage technique, first described by Hankin in 1984, offers an alternate single-person technique for the reduction.

With this technique, the clinician interlocks their fingers with the patient’s fingers in a clasping grip 

https://www.annemergmed.com/cms/10.1016/j.annemergmed.2022.04.029/asset/193d863a-9e37-4bb7-99d5-c13f7dce68c7/main.assets/gr5_lrg.jpg

If the patient has a longer forearm length than the clinician, grasp the patient’s wrist instead of their fingers for this technique. 

The clinician then places their elbow against the distal portion of the patient’s biceps muscle until tension is felt on the patient’s flexed arm.

The clinician then slowly draws the patient’s arm into hyperflexion, using their elbow as a fulcrum at the patient’s elbow joint. 

The clinician can use their other hand to guide the patient’s olecranon over the distal humerus. 

A modification has also been described, wherein the clinician uses their contralateral hand to apply a distracting force on the patient’s forearm.

Hankin reported that all 77 cases were successfully reduced without complications using this technique, and another study reported a 100% success rate (10 dislocations). 

Key advantages

  • No assistant required — performed by a single operator 
  • No special equipment needed
  • Uses leverage rather than brute force, reducing soft tissue trauma


Title: How much oxygen after cardiac arrest: LOGICAL trial

Category: Critical Care

Keywords: cardiac arrest, ischemic encephalopathy, ROSC, post arrest care (PubMed Search)

Posted: 8/8/2026 by Zach Wynne, MD

Bottom Line

This trial showed that the percentage of mechanically ventilated patient post arrest who received conservative oxygen therapy (SaO2 90-95%) with favorable neurological outcomes was not significantly different compared to the percentage of patients who received liberal oxygen therapy (minimum FiO2 of 0.3, SaO2 > 90%). While avoiding hypoxemia along with hypercapnia remains a hallmark of post arrest care, exact oxygenation goals above SaO2 of 90% remain unclear.

Show Additional Information

LOGICAL trial - NEJM Aug 2026

Background:

Patients who are status post cardiac arrest remain some of the sickest patients in medicine, requiring optimization of physiologic markers to promote the best neurological outcome. One of the most important parameters is oxygenation. However, exact oxygenation goals have been unclear with some trials showing benefit to using more conservative (lower) oxygenation targets in hopes of preventing neuronal death from relative hyperoxia and reperfusion injury. Thus, the Low Oxygen Intervention for Cardiac Arrest Injury Limitation (LOGICAL) trial was conducted.

Patients: > 18 years old mechanically ventilated with suspected ischemic encephalopathy from 53 ICU's in Australia, New Zealand, and Ireland. Exclusions included previous enrollment or inappropriate to enroll (such as imminent death)

Intervention: Conservative oxygen therapy defined as SaO2 goal of 90-95% with alarms for outside these parameters; FiO2 could be increased if SaO2 at goal but PaO2 < 60 mmHg

Control: Liberal oxygen therapy defined as Sa02 goal > 90% with alarms for below this parameter; FiO2 was at 0.3 minimum for mechanical ventilation

Outcome: Extended Glasgow Outcome Scale (GOS-E) score of 5-8 at 180 days reflecting lower moderate disability to upper good recovery ("favorable neurological outcome"); other outcomes include all cause and specific mortality, duration of mechanical ventilation/ICU stay/hospital stay, and discharge to home

Results:

1840 patients enrolled with 1821 analyzed by intention to treat. There were similar baseline characteristics between groups. Less than 1% of patients in each group did not receive assigned conservative/liberal treatment. 26.3% of patients in the conservative oxygen group failed to have FiO2 weaned and 8.4% of liberal oxygen group had an FiO2 less than 0.3. 

A favorable GOS-E (5-8) was observed in 38.2% of the conservative oxygen therapy group vs. 39.7% in the liberal oxygen therapy group (RR of 0.97, p = 0.65). Secondary outcomes showed no statistically significant difference.

Discussion:

Overall, the trial did not find a statistically significant difference in favorable neurological outcome or other outcomes in conservative vs. liberal oxygen therapy. The protocol deviations, noted above, likely lessened between-group difference in oxygen exposure. Additionally, time from ROSC to randomization was longer than previous studies which likely did not have a large effect. The trial adds to the literature that conservative oxygen therapy does not lead to improved neurological outcomes compared to liberal oxygen therapy. 

In my practice of patient including post arrest patients, I continue to aim for an SaO2 of mid 90's for most of my patients, avoiding hypoxemia (SaO2 < 90% generally) or the persistent SaO2 of 100.

Show References

  • LOGICAL Investigators and the Australian and New Zealand Intensive Care Society Clinical Trials Group; Hodgson CL et al. Conservative Oxygen for Unresponsive Patients after Cardiac Arrest. N Engl J Med. 2026 Aug 6;395(6):571-581. doi: 10.1056/NEJMoa2513814. Epub 2026 Jun 10. PMID: 42267831.


Title: BUCKLED Trial (POCUS for Pediatric Distal Forearm Fractures)

Category: Pediatrics

Keywords: POCUS, ultrasound, distal forearm fracture, buckle fracture, pediatric orthopedics, imaging (PubMed Search)

Posted: 8/7/2026 by Jeremy St. Thomas, MD (Updated: 8/7/2026)

One-liner:

Point-of-care ultrasound was noninferior to radiographs for diagnosing distal forearm buckle fractures while improving patient experience.

Summary:

Background: Distal forearm buckle fractures are among the most common pediatric fractures and are often straightforward to diagnose. 

Methods: Multicenter randomized trial comparing ultrasound-first evaluation with conventional radiography (n=270). 

Results: Ultrasound accurately diagnosed buckle fractures with similar clinical outcomes. Families reported greater satisfaction, ED length of stay decreased, and radiation exposure was avoided. 

Limitations: Requires physician ultrasound training. Results apply primarily to uncomplicated distal forearm injuries. 

Clinical Relevance: Supports expanding POCUS use for selected pediatric orthopedic injuries and reducing unnecessary radiographs. 

Take-home Points:

POCUS is an effective first-line imaging modality, ideal for experienced ultrasound users.  

Shorter ED stays.  

Eliminates radiation.

Show Additional Information

Show References

Snelling PJ, Jones P, Bade D, Bindra R, Byrnes J, Davison M, George S, Moore M, Keijzers G, Ware RS; BUCKLED Trial Group. Ultrasonography or Radiography for Suspected Pediatric Distal Forearm Fractures. N Engl J Med. 2023 Jun 1;388(22):2049-2057. doi: 10.1056/NEJMoa2213883. PMID: 37256975.



Title: Prehospital trauma airway data

Category: Trauma

Posted: 8/6/2026 by Robert Flint, MD (Updated: 8/12/2026)

Looking at a national EMS database, these authors found advanced airway management (intubation, cricothyrotomy, rescue devices) occurred in 4/1000 trauma patients. Firearm related injury and motorcycle crashes had the highest use rate. Firearm related injury had the highest use rate of cricothyrotomy.  This data should help drive prehospital education.

Show References

Prehospital Emergency Care

https://doi.org/10.1080/10903127.2026.2618587



Title: "Fab"-ulous snake antivenoms!

Category: Toxicology

Keywords: snake bite, envenomation, antivenom (PubMed Search)

Posted: 8/5/2026 by Kathy Prybys, MD

Bottom Line:

The most effective treatment for snake bite envenomation is prompt administration of antivenom which neutralizes venom toxins. Early administration has been shown to improve clinical outcomes by stopping progression of venom effects however it cannot reverse tissue injury that has already occurred making early treatment critical. The potential risk of causing an adverse reactions in non-envenomated patients must be weighed against the benefit of giving antivenom early in patients with significant envenomation.

Show Additional Information

Worldwide, an estimated 5.4 million snake bites occur every year with approximately 25-50% envenomation rate causing up to 138,000 deaths, and causing permanent sequelae in greater than 400,000 victims according to the World Health Organization (WHO).  Snake bites is recognized by the WHO as a high-priority neglected tropical disease. In the United States, approximately 7000-8000 snake bites occur annually with an average of 5-10 deaths per year.  Approximately 98% of snake envenomations in the U.S. are due to crotalid family: rattlesnakes, copperheads, and water moccasins.

Snakes are ectothermic (“cold-blooded”) animals that rely on environmental heat sources rather than internal metabolic processes to regulate temperature.  During colder months, snakes enter a state of brumation and become less active, reducing their metabolic and bodily functions. They seek shelter usually in underground dens and require little to no food. In nontropical areas, snake bite incidence peaks during the hottest time of the year from spring through fall with most activity occurring in the cooler parts of the day (morning and dusk).

 Humans are not prey for snakes. Most bites occur as result of a defensive strike after perceiving a threat. Snakes may only deliver a warning bite and release no venom (aka ”dry bite”) to preserve their venom for future hunting of prey. 

Snake venom is a highly complex mixture of over a hundred different peptides, proteins, enzymes, and other bioactive  components which produce local tissue damage, hematologic abnormalities, and systemic effects.  Envenomation severity depends on the amount of venom injected, venom composition, location of bite, and host specific factors. Distinguishing a dry bite from a true envenomation can be difficult as any bite can cause pain, swelling, inflammation, and emotional distress.

 Clinical signs of envenomation and severity include progressive local tissue damage (pain, swelling, discoloration, blistering, tissue necrosis), hematologic effects (coagulopathy or bleeding), and systemic signs attributable to venom (weakness, paresthesia, nausea, hypotension altered mental status). Patients should be reassessed every 2 hours, as clinical findings may evolve rapidly. 

  • Envenomation can be excluded when there are no local or systemic signs and laboratory studies remain normal after 6- 8 hours observation
  • Patients with signs and symptoms of envenomation should be observed for 12-24 hours for signs of clinical progression

Laboratory analyses should include complete blood count, platelet count, PT, PTT, serum fibrinogen level, complete metabolic panel, and creatinine kinase with repeat testing every 6 hours to gauge response to therapy and guide additional antivenom therapy.

Two crotalid antivenoms approved by the FDA are currently on the market for treatment of North American pit viper envenomations: Crofab® and Anavip®. Both are derived from either immunized sheep or horses and fractionated to obtain the less antigenic, smaller, and specific Fab fragments of IgG antibodies. During administration, patients should be closely monitored for adverse reactions and anaphylaxis which most commonly seen within the first few minutes of administration but may develop up to 2 hours after. 

CroFab® was first released in 2000, is a F(ab’)1 antivenin product derived from sheep immunized with Western Diamondback rattlesnake (Crotalus atrox), Eastern Diamondback rattlesnake (Crotalus adamanteus), Mojave rattlesnake (Crotalus scutulatus), and the Cottonmouth, or Water Moccasin, (Agkistrodon piscivorus). It has a single toxin binding site and smaller  molecular size allowing for good tissue penetration and shorter half-life and elimination.

  • Starting dose: 4-6 vials with treatment goal to stop progression of soft tissue swelling and coagulopathy
  • Give additional 4-6 vials in 1 hour if treatment goals are not met. No max dose. The dose of antivenom required is proportional to the amount of venom injected. 
  • Administer additional 2 vials every 6 hours for 3 doses to prevent recurrence
  • Research of copper head bites treated with early administration of CroFab show improved outcome (faster recovery, less need for opioids, and reduced risks of prolonged, possibly permanent disability) and lack of need for maintenance dose.

Anavip® was released in 2018 and is an equine derived F(ab?)2 antivenin product derived from horses immunized with Mexico/Central American snakes: Bothrops asper and Crotalus durissus.  It has two toxin binding sites, larger molecular size, and a longer half-life. 

  • Initial dose: 10 vials - if initial control is not obtained repeat dose as needed every hour. No max dose
  • Because of its longer half-life compared to Crofab®, no maintenance dose is usually required
  • Studies demonstrated a lower incidence of late onset or recurrent coagulopathy when compared to Crotab® likely due to its longer elimination half-life

Show References

The association between ambient temperature and snakebite in Georgia, USA: A case-crossover study. Landry, M., D’Souza, R., Moss, S., et al, GeoHealth, 7, 2023. e2022GH000781. https://doi.org/10.1029/2022GH000781

The chemistry of snake venom and its medicinal potential. Oliveira AL, Viegas MF, da Silva SL, et al.  Nat Rev Chem. 2022;6(7):451-469. doi: 10.1038/s41570-022-00393-7. Epub 2022 Jun 10. PMID: 35702592; PMCID: PMC9185726.

Snakebite envenoming: A systematic review and meta-anaylysis of global morbidity and mortality. Afroz A, Siddiquea BN, Chowdhury HA, et al. 2024. PLOS Neglected Tropical Diseases 18(4): e0012080. https://doi.org/10.1371/journal.pntd.0012080

Long-Term Clinical Outcomes of Rattlesnake Envenomation in Arizona Following Treatment With Crofab vs Anavip: A Retrospective Observational Study. Smelski GT, Guthrie AM, Axon DR, et al. J Am Coll Emerg Physicians Open. 2025 Jun 12;6(4):100207. doi: 10.1016/j.acepjo.2025.100207. PMID: 40574792; PMCID: PMC12197915.

Efficacy and safety of two Antivenoms in the treatment of eastern copperhead (Agkistrodon contortrix) envenomations in Southeast Texas, Spencer Greene, Alexander Teshon, JACEP Open,Volume 5, Issue 5, 2024,e13310,ISSN 2688-1152,https://doi.org/10.1002/emp2.13310.

 The critical time period for administering antivenom: golden hours and missed opportunities. Isbister, G. K. 2024.Clinical Toxicology, 62(5), 277–279. https://doi.org/10.1080/15563650.2024.2352026



Title: POCUS Ocular

Category: Ultrasound

Keywords: POCUS, ocular, lens dislocation (PubMed Search)

Posted: 8/3/2026 by Alexis Salerno Rubeling, MD

Question

What's the diagnosis?

Show Answer

Lens dislocation occurs when the lens is displaced posteriorly into the vitreous humor or posterior chamber. This typically occurs post-surgery or as the result of trauma, but it can also be secondary to a genetic predisposition (eg, connective tissue disorder).  

  •  A complete lens dislocation will appear as a hyperechoic annular structure that is usually mobile in the vitreous humor or posterior chamber 
  • A partial lens dislocation may show the lens in the normal position while the patient is supine but show that it is detached when the patient is sitting upright, or it may show one side detached.

Photo Credit: Dr. Michael Sullivan

Show References

Pierre VA, Smith T, Salerno A. Ocular Ultrasound. Emerg Med Clin North Am. 2024 Nov;42(4):891-903. doi: 10.1016/j.emc.2024.05.009. Epub 2024 Aug 17. PMID: 39326993.



Title: PIT and radiology utilization

Category: Administration

Keywords: Pit, utilization, imaging (PubMed Search)

Posted: 8/2/2026 by Robert Flint, MD (Updated: 8/12/2026)

This single center study at an academic center compared pre and post provider in triage implementation radiology ordering rate. They found higher CT utilization and lower positive CT findings in the post implementation period.  Further work is needed, however is provider in triage good medicine or good for metric numbers?

Show References

Thom C, Spirek B, Mullins C, Moak J. Quantity matters: Impact of PIT deployment on advanced imaging utilization. Am J Emerg Med. 2026 Jul;105:109-114. doi: 10.1016/j.ajem.2026.04.009. Epub 2026 Apr 8. PMID: 42000674.



Title: Asthma visits and wildfire smoke

Category: Pulmonary

Keywords: Asthma wildfire smoke pollution (PubMed Search)

Posted: 8/1/2026 by Robert Flint, MD (Updated: 8/12/2026)

In 2023 there was a similar Canadian wildfire smoke pollution issue in the United States as there was in July 2026. The CDC found: 

“Emergency department visits for asthma were 17% higher than expected during 19 days of wildfire smoke that occurred during April–August 2023.”

Show References

McArdle CE, Dowling TC, Carey K, et al. Asthma-Associated Emergency Department Visits During the Canadian Wildfire Smoke Episodes — United States, April– August 2023. MMWR Morb Mortal Wkly Rep 2023;72:926–932. DOI: http://dx.doi.org/10.15585/mmwr.mm7234a5.



Title: Freeze Dried Plasma

Category: Trauma

Posted: 7/30/2026 by Robert Flint, MD (Updated: 8/12/2026)

The US FDA has approved the first freeze dried plasma. It is stored at room temperature in plastic bags which makes it ideal for austere environments. It is easily reconstituted and is given to patients who require plasma,  bypassing the need to thaw FFP.

Show References

https://www.fda.gov/news-events/press-announcements/fda-licenses-first-ever-freeze-dried-plasma-product-us



Title: Medium Vessels, Major Questions: Is Thrombectomy Worth the Risk?

Category: Neurology

Keywords: stroke, thrombectomy, neurology (PubMed Search)

Posted: 7/27/2026 by Lena Carleton, MD (Updated: 7/27/2026)

Bottom Line: In patients with acute ischemic stroke due to medium or distal vessel occlusion, mechanical thrombectomy did not improve functional outcomes at 3 months and was associated with an increased risk of symptomatic intracranial hemorrhage.

Show Additional Information

In this randomized clinical trial conducted at 22 stroke centers in France, patients with acute ischemic stroke, an NIHSS score of ?5 or significant aphasia, and a medium or distal vessel occlusion were randomized to medical therapy or mechanical thrombectomy. A total of 244 patients were enrolled, and the primary outcome was the modified Rankin Scale score at 3 months. The trial was stopped early because thrombectomy was associated with an increased risk of symptomatic intracranial hemorrhage. 

Show References

Clarençon F, Bala F, Baptiste A, et al. Mechanical Thrombectomy in Ischemic Stroke With a Medium or Distal Arterial Occlusion: The DISCOUNT Randomized Clinical Trial. JAMA. Published online July 22, 2026. doi:10.1001/jama.2026.8977



Title: Perceived vs actual barriers post ED discharge

Category: Administration

Keywords: discharge barriers (PubMed Search)

Posted: 7/26/2026 by Robert Flint, MD

This single center study asked patients about barriers to health carrier after ED discharge (example transportation, lack of PCP, inability afford medications, trouble with ADLs) and then surveyed EM residents about those same patients' barriers. Resident physicians way under perceived barriers to care in their patients. ("20.4% of patients reported they had no primary care physician (PCP) and 9.8% of residents reported their patient had no PCP . Limited health literacy was identified in 59.0% of patients and reported by 37.6% of residents . Abnormal cognition was present in 53.6% of adults age ??65 and reported by 16.7% of residents .")

Another example of if you do not ask, you will not know. Be careful of assumptions.

Show References

T. K. Hagerman, F. I. Mowbray, T. Lang, et al., “ Overlooking Barriers to Safe and Effective Emergency Department Discharge,” Academic Emergency Medicine 33, no. 5 (2026): e70320, https://doi.org/10.1111/acem.70320.



Title: Is a 6 pack a day good for cognitive functioning?

Category: Misc

Keywords: cognitive functioning, dementia (PubMed Search)

Posted: 7/25/2026 by Brian Corwell, MD (Updated: 8/12/2026)

What is its just diet coke?

Show Additional Information

A new observational study of almost 13,000 Brazilian adults looked at the association between zero and low calorie sweeteners and cognitive function.

Published in Neurology.

A prospective cohort study: mean age 51.9 ± 9.0 years, 54.8% women, 43.2% Black/mixed race.

Followed for a median of 8 years.

Data from the ELSA-Brasil cohort.

Dietary intake of low- and no-calorie sweeteners (LNCSs) was assessed via food frequency questionnaire.

They included: aspartame, saccharin, acesulfame k, erythritol, xylitol, sorbitol, and tagatose

Sucralose could not be assessed because it was approved in Brazil during the study's dietary assessment period. 

Participants were grouped by average daily sweetener intake into High (avg 191mg/day), medium and low (20mg/day) consumption groups.

Cognitive function was measured serially across memory, verbal fluency, and executive function domains.

Adjusted for age, sex, HTN, CV disease.

What did they find?

The highest consumption group of combined LNCSs was associated with faster decline in verbal fluency and global cognition, particularly among participants younger than 60 years.

The highest intake group experienced a 62% faster rate of cognitive decline than the lowest intake group… equivalent to roughly 1.6 years of additional brain aging.

The middle consumption group showed a 35% faster cognitive decline vs. the lowest intake group.

No significant association was found in those aged over 60 years. 

When individual sweeteners were analyzed, aspartame, saccharin, acesulfame K, erythritol, sorbitol, and xylitol were each independently associated with faster decline in global cognition, with memory and verbal fluency most affected.

Tagatose was the only sweetener not associated with cognitive decline. 

         Tagatose is often found in dairy products, because it is formed when milk is heated. It is similar in texture and appearance to sucrose and is 92% as sweet but with only 38% of the calories.

The association was more pronounced in participants with diabetes though those without diabetes also showed associations with faster decline in verbal fluency and global cognition.

Consider that individuals with diabetes are more likely to consume LNCSs because of medical advice to reduce sugar consumption.

No association was found between any LNCS and performance of executive function.

Important Limitations and Context

This is an observational study and cannot establish causation. 

Using self-reported dietary information is notoriously inaccurate.

Take Home: Multiple artificial sweeteners (Not just sweetened beverages) are associated with cognitive decline ESPECIALLY  in midlife and in those with diabetes.

Show References

Gonçalves NG,  et al. Association Between Consumption of Low- and No-Calorie Artificial Sweeteners and Cognitive Decline: An 8-Year Prospective Study. Neurology. 2025 Oct 7



Title: Geriatric suicidal ideation presentations

Category: Geriatrics

Keywords: Suicidal ideation, older, geriatric (PubMed Search)

Posted: 7/23/2026 by Robert Flint, MD (Updated: 8/12/2026)

This Canadian study looking at older patients presenting to EDs with suicidal ideation or attempt found most were female, arrived by ambulance from home, had poor social determinates of health, had a mental health history and attempts were by poisoning. Similar risk factors to other age groups. Mental health conditions donot tend to improve with age.

Show References

V. Boucher, A.-P. Gagnon, P.-A. Tardif, et al., “ Suicidal Ideation and Attempts in Older Adults: Findings From Five Canadian Emergency Departments,” Journal of the American Geriatrics Society (2026): 1–10, https://doi.org/10.1111/jgs.70464.



Title: AI-Driven HPI?

Category: Administration

Keywords: Artificial intelligence, HPI, medical history, Emergency department, emergency practice (PubMed Search)

Posted: 7/22/2026 by Mercedes Torres, MD (Updated: 8/12/2026)

The common teaching that “the key to diagnosis is in the HPI” holds true for many of the patients we care for in the ED.  

But, what if ChatGPT was tasked with obtaining the initial HPI rather than the provider?  How accurate/reliable can a ChatGPT-driven history prove to the physician, or seem to the patient?  

Researchers in the field of AI applications are beginning to tackle these questions as emergency departments pilot AI-driven history platforms to leverage time spent in the waiting room with a goal of improving efficiency and provider workload.  What do you think?  

Click the link to see a summary of some interesting findings in this pilot study conducted in a large urban pediatric ED waiting room.

Show Additional Information

  • Physician reviewers rated ChatGPT-derived HPI summaries favorably across accuracy, completeness, efficiency, readability, and overall satisfaction.
  • Patients and caregivers reported high satisfaction and ease of use with the process of providing an HPI through ChatGPT and described the interaction as similar to speaking to a clinician.
  • Some patient's felt that the AI-interaction helped them prepare for the actual conversation with the clinician, reminding them of important symptoms to mention.
  • No hallucinations were reported.
  • There were some key omissions and errors which were caught when summaries were reviewed by the patients/caregivers and clinicians.
  • Trade-offs included decreased patient-clinician interaction which may impede the relationship-building aspect of history-taking and fewer nonverbal cues between the patient and the clinician.

Show References

Morley-Fletcher A, Raghavan V, Geanacopoulos A, et al. A Pilot Study to Evaluate Artificial Intelligence-Driven Early Retrieval of Medical Histories in the Emergency Department. Annals of Emergency Medicine, 2026; 88, 135-143.



Title: Therapeutic AC May Shorten Time to Resolution of Acute Chest Syndrome in Adults

Category: Critical Care

Keywords: acute chest syndrome, microthrombi, pulmonary vasoocclusion, sickle cell disease, anticoagulation (PubMed Search)

Posted: 7/21/2026 by Jessica Downing, MD (Updated: 8/12/2026)

A multicenter double-blind RCT published in 2025 found that adult patients hospitalized with acute chest syndrome (ACS) who received 7 days of prophylactic therapeutic anticoagulation had a shorter time to ACS resolution (by approx 1 day) and reduced opioid consumption when compared to those receiving standard VTE prophylaxis.

Show Additional Information

Acute Chest Syndrome (ACS) is known to be associated with severe pulmonary vascular dysfunction. Prior studies have identified local vaso-occlusion leading to pulmonary infarct as the underlying etiology of up to 16% of ACS episodes, and have demonstrated relatively high rates of PE and pulmonary microthrombi. 

The TASC (Therapeutic Anticoagulation for Acute Chest Syndrome in Sickle Cell Disease) trial randomly assigned adult patients hospitalized for acute chest syndrome with no PE on CTA to prophylactic or therapeutic low-molecular weight heparin for 7 days or until hospital discharged. 172 patients were randomized - 84 in the prophylactic-dose group and 88 in the therapeutic-dose group. Patients in the therapeutic-dose group had a shorter time to ACS resolution (4.8?±?0.4 days vs. 6.1?±?0.5 days, HR 0.71; 95% CI 0.51–0.99; P?=?0.044 ). There were no major bleeding events in either group. The therapeutic dose group used an almost 45% lower cumulative dose of parenteral opioids (124 vs 219 morphine equivalent units, difference ?96; 95% CI ?202 to ?46; P?=?0.02).

Details:

  • ACS was defined by: new pulmonary infiltrate on CXR or CT AND respiratory symptom (s) OR abnormality on pulmonary auscultation
  • ACS resolution was defined by “joint improvement of four criteria, including fever, chest pain, dyspnea, and hypoxemia.” The hypoxemia component was excluded in the 62% of patients who were not hypoxemic at baseline. 
  • Study setting: across 12 health centers in France from 2016-2021.
  • Key exclusion criteria: 
    • Age < 18
    • ACS diagnosed >48h prior
    • Body weight <40kg or >100kg
    • CrCl <60 ml/min (if enrolled, treatment was discontinued if a patient developed severe AKI with CrCl <30 ml/min)
    • RBC transfusion “deemed highly risky”
    • Interestingly, the presence or absence of active COVID infection was not discussed
  • The anticoagulation used here was tinzaparin (a type of  low-molecular-weight heparin that is FDA approved but has been discontinued in the US; it has a higher molecular weight and greater anti-thrombin activity than enoxaparin). Prophylactic dosing was 4500 IU/24h and therapeutic dosing was 175 IU/kg/24h (both standard dosing for their indications).

Show References

Mekontso Dessap A, Habibi A, Arlet JB, Fartoukh M, Guerin L, Guillaud C, Roux D, Oziel J, Ngo S, Carpentier B, Lopez-Sublet M, Affo L, Melica G, Etienne-Julan M, Delacroix I, Lionnet F, Loko G, Da Silva D, Michel M, Razazi K, Charles-Nelson A, Bartolucci P, Gendreau S, Katsahian S, Maitre B. Comparison of Prophylactic and Therapeutic Doses of Anticoagulation for Acute Chest Syndrome in Sickle Cell Disease: The TASC Double-Blind Controlled Randomized Clinical Trial. Am J Respir Crit Care Med. 2025 May;211(5):832-841. doi: 10.1164/rccm.202409-1727OC. PMID: 40209087.



Title: POCUS compared to consultative echo for RV dysfunction

Category: Ultrasound

Keywords: POCUS, echocardiography, pulmonary embolism (PubMed Search)

Posted: 7/20/2026 by Alexis Salerno Rubeling, MD (Updated: 8/12/2026)

POCUS has moderate agreement with cardiology consultative echocardiography for RV strain in the setting of acute pulmonary embolism. Accuracy and agreement increase as the degree of RV dysfunction increases.

Show Additional Information

A recent study looked at a retrospective cohort of 194 patients diagnosed with pulmonary embolism. POCUS RV strain was described as RV>LV and/or a low TAPSE. POCUS had a 76.8% sensitive and 85.9% specific for the identification of right ventricular dysfunction compared with consultative echocardiography. There was moderate agreement for RV strain. There were improved sensitivity and agreement when the severity of RV dysfunction increased. Specificity was highest among PGY-1 residents, whom at the study institution scan with ultrasound faculty. Sensitivity increased with training levels.

Show References

Thomas AL, Rupp JD, Suszanski J, Storrow AB, Kline JA, Birrenkott DA, Kabrhel C, Wrenn JO, Stubblefield WB. Accuracy of Point-of-Care Ultrasound Versus Consultative Echocardiography to Identify Right Ventricular Dysfunction in Emergency Department Patients With Pulmonary Embolism. Ann Emerg Med. 2026 Jun 18:S0196-0644(26)00308-2. doi: 10.1016/j.annemergmed.2026.05.003. E



Previous |  1 |  2 |  3 |  4 |  5 |  6 |  ... |  237 |  Next
University of Maryland School of Medicine logo
  • Departments
  • Programs
  • Research Centers
  • Institutes
  • Graduate Education
  • CIBR Cores
  • Offices of the Dean
    • University of Maryland, Baltimore
    • University of Maryland Medical Center
    • Medical Alumni Association of the University of Maryland
    • Health Sciences and Human Services Library
University of Maryland School of Medicine
655 W. Baltimore Street
Baltimore, MD 21201
Contact Us

© University of Maryland School of Medicine

    • Webmaster
    • Web Accessibility
    • Site Index
    • UMB Hotline
    • Employment
    • Map